Retour
34
Également cotée sous
MAHLY
OTC
Fourchette du Jour
19,00 €
19,00 €
Fourchette 52 Semaines
14,75 €
19,00 €
Volume
200
Moyenne 50J / 200J
18,50 €
/
16,78 €
Clôture Précédente
19,00 €
Quick Summary
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (631 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 0,1 | 0,2 |
| P/B | 0,0 | 3,0 |
| ROE % | 6,6 | 3,5 |
| Net Margin % | 1,1 | 3,8 |
| Rev Growth 5Y % | 3,4 | 9,7 |
| D/E | 0,0 | 0,2 |
Objectif de Cours des Analystes
Aucune couverture d'analyste disponible
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
1,36 €
1,34 € – 1,37 €
|
4,21T | 1 |
| FY2029 |
1,28 €
1,27 € – 1,30 €
|
4,02T | 1 |
| FY2028 |
1,21 €
1,20 € – 1,23 €
|
3,98T | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-09 | 0,32 € | 0,48 € | +48,4% |
| 2025-11-05 | 0,26 € | 0,41 € | +57,7% |
| 2025-08-05 | 0,32 € | 0,32 € | -0,6% |
| 2025-05-12 | 0,11 € | 0,13 € | +17,5% |
| 2025-02-10 | 0,22 € | 0,44 € | +100,6% |
| 2024-11-01 | 0,37 € | 0,43 € | +14,7% |
| 2024-08-01 | 0,35 € | 0,27 € | -23,9% |
| 2024-05-14 | 0,27 € | 0,41 € | +52,1% |
Dividend History
7 yr streakYield
0,02%
Payout Ratio
0,31%
Growth (3Y)
7,31%
Growth (5Y)
1,81%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 31, 2026 | Mar 30, 2026 | 0,22 € | 2,28% |
| Sep 30, 2025 | Dec 02, 2025 | 0,22 € | 2,70% |
| Mar 31, 2025 | Jun 03, 2025 | 0,21 € | 2,53% |
| Sep 30, 2024 | Dec 03, 2024 | 0,21 € | 3,09% |
| Mar 28, 2024 | Jun 04, 2024 | 0,20 € | 2,43% |
| Sep 28, 2023 | Dec 04, 2023 | 0,20 € | 2,88% |
| Mar 30, 2023 | Jun 02, 2023 | 0,17 € | 2,56% |
| Sep 29, 2022 | Dec 02, 2022 | 0,16 € | 2,54% |
| Mar 30, 2022 | Jun 02, 2022 | 0,19 € | 2,02% |
| Sep 29, 2021 | Dec 02, 2021 | 0,19 € | 1,93% |
| Mar 30, 2021 | Jun 02, 2021 | 0,19 € | 1,80% |
| Sep 29, 2020 | Dec 02, 2020 | 0,20 € | 2,01% |
| Mar 30, 2020 | Jun 02, 2020 | 0,19 € | 2,08% |
| Sep 27, 2019 | Dec 03, 2019 | 0,19 € | 1,71% |
| Mar 27, 2019 | Jun 04, 2019 | 0,18 € | 1,46% |
| Sep 26, 2018 | Dec 04, 2018 | 0,16 € | 3,12% |
| Mar 28, 2018 | Jun 04, 2018 | 0,17 € | 2,96% |
| Sep 27, 2017 | Dec 04, 2017 | 0,14 € | 2,72% |
| Mar 29, 2017 | Jun 02, 2017 | 0,14 € | 2,78% |
| Sep 28, 2016 | Dec 02, 2016 | 0,15 € | 2,67% |
Points Clés
Revenue grew 3,40% annually over 5 years — modest growth
Debt/Equity of 0,00 — conservative balance sheet
Generating 48,13B in free cash flow
P/E of 0,10 — trading at a low valuation
Cash machine — converts 119,49% of earnings into free cash flow
Capital efficient — spends only 0,34% of revenue on capex
Croissance
Revenue Growth (5Y)
3,40%
Revenue (1Y)3,16%
Earnings (1Y)-2,88%
FCF Growth (3Y)326,81%
Qualité
Return on Equity
6,60%
ROIC6,73%
Net Margin1,10%
Op. Margin1,51%
Sécurité
Debt / Equity
0,00
Current Ratio1,27
Interest Coverage7944,14
Valorisation
P/E Ratio
0,10
Forward P/E15,24
P/B Ratio0,01
EV/EBITDA-4,63
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 3,16% | Revenue Growth (3Y) | 4,53% |
| Earnings Growth (1Y) | -2,88% | Earnings Growth (3Y) | 1,88% |
| Revenue Growth (5Y) | 3,40% | Earnings Growth (5Y) | 13,91% |
| Profitability | |||
| Revenue (TTM) | 3,67T | Net Income (TTM) | 40,28B |
| ROE | 6,60% | ROA | 2,21% |
| Gross Margin | 6,97% | Operating Margin | 1,51% |
| Net Margin | 1,10% | Free Cash Flow (TTM) | 48,13B |
| ROIC | 6,73% | FCF Growth (3Y) | 326,81% |
| Safety | |||
| Debt / Equity | 0,00 | Current Ratio | 1,27 |
| Interest Coverage | 7944,14 | ||
| Dividends | |||
| Dividend Yield | 0,02% | Payout Ratio | 0,31% |
| Dividend Growth (3Y) | 7,31% | Dividend Growth (5Y) | 1,81% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 0,10 | Forward P/E | 15,24 |
| P/B Ratio | 0,01 | P/S Ratio | 0,00 |
| PEG Ratio | -9,71 | Forward PEG | N/A |
| EV/EBITDA | -4,63 | Fwd EV/EBITDA | -3,45 |
| Forward P/S | 0,00 | Fwd Earnings Yield | 6,56% |
| FCF Yield | 1237,45% | ||
| Market Cap | 3,89B | Enterprise Value | -257,52B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3,67T | 3,56T | 3,36T | 3,29T | 3,21T |
| Net Income | 40,28B | 41,47B | 38,81B | 29,42B | 23,93B |
| EPS (Diluted) | 193,20 | 195,83 | 179,12 | 131,41 | 106,80 |
| Gross Profit | 255,76B | 246,66B | 224,31B | 217,45B | 214,26B |
| Operating Income | 55,61B | 47,33B | 48,97B | 45,62B | 38,58B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,82T | 1,80T | 1,70T | 1,71T | 1,68T |
| Total Liabilities | 1,07T | 1,06T | 1,02T | 1,06T | 1,04T |
| Shareholders' Equity | 619,56B | 600,35B | 561,36B | 530,30B | 523,01B |
| Total Debt | 0,0 | 1,46B | 7,38B | 30,08B | 30,58B |
| Cash & Equivalents | 261,41B | 230,15B | 195,03B | 243,15B | 222,75B |
| Current Assets | 1,28T | 1,24T | 1,18T | 1,21T | 1,17T |
| Current Liabilities | 1,01T | 1,01T | 971,52B | 1,01T | 952,84B |
Scores de Stratégies
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#577 of 826
Activité Récente
Sorti
Defensive Investing (Benjamin Graham)
Mar 26, 2026
Entré
Deep Value Investing (Seth Klarman)
Mar 24, 2026
Entré
Defensive Investing (Benjamin Graham)
Mar 24, 2026